LexisNexis® CLE On-Demand features premium content from partners like American Law Institute Continuing Legal Education and Pozner & Dodd. Choose from a broad listing of topics suited for law firms, corporate legal departments, and government entities. Individual courses and subscriptions available.
INDIANAPOLIS - (AP) Eli Lilly & Co. on Thursday lowered its revenue outlook for the year after it lost a patent lawsuit over its attention deficit hyperactivity drug Strattera. The U.S. District Court for the District of New Jersey ruled against the company, saying its method-of-use patent. . . . Full version available to lexis.com subscribers.